The AIM-HI Women’s Venture Competition, in its third year, provides early-stage funding, coaching, and networking opportunities to women-led oncology startups to address unmet medical needs. Cash prizes will be awarded to the top three finalists. The winning company will receive a total of $1 million in equity investment from AIM-HI and co-investors, subject to due diligence and negotiation. The funding is intended for the startups to generate data for proof of concept and proof of value, on the path to clinical trials and, eventually, to new effective therapeutics and diagnostics that could save patients’ lives.

Please click here to learn more about the Women’s Venture Competition.